Mechanical explanation of nature and its limits in Kant's Critique of judgment [0.03%]
康德《判断力批判》中的机械自然观及其限度
Angela Breitenbach
Angela Breitenbach
In this paper I discuss two questions. What does Kant understand by mechanical explanation in the Critique of judgment? And why does he think that mechanical explanation is the only type of the explanation of nature available to us? Accordi...
Kant on epigenesis, monogenesis and human nature: the biological premises of anthropology [0.03%]
康德论人类的发生、单源和天性：人类学的生物学前提
Alix A Cohen
Alix A Cohen
The aim of this paper is to show that for Kant, a combination of epigenesis and monogenesis is the condition of possibility of anthropology as he conceives of it and that moreover, this has crucial implications for the biological dimension ...
Naturalising purpose: from comparative anatomy to the 'adventure of reason' [0.03%]
目的的自然化：从比较解剖学到“理性之旅”
Philippe Huneman
Philippe Huneman
Kant's analysis of the concept of natural purpose in the Critique of judgment captured several features of organisms that he argued warranted making them the objects of a special field of study, in need of a special regulative teleological ...
Kant on the history of nature: the ambiguous heritage of the critical philosophy for natural history [0.03%]
康德论自然史：批判哲学对自然历史的遗产之不确定性
Phillip R Sloan
Phillip R Sloan
This paper seeks to show Kant's importance for the formal distinction between descriptive natural history and a developmental history of nature that entered natural history discussions in the late eighteenth century. It is argued that he de...
The promise of pharmacogenetics: assessing the prospects for disease and patient stratification [0.03%]
药物遗传学的前景：评估疾病和患者分层的可能性
Andrew Smart,Paul Martin
Andrew Smart
Pharmacogenetics is an emerging biotechnology concerned with understanding the genetic basis of drug response, and promises to transform the development, marketing and prescription of medicines. This paper is concerned with analysing the mo...
Adam M Hedgecoe
Adam M Hedgecoe
Most of the literature on pharmacogenetics assumes that the main problems in implementing the technology will be institutional ones (due to funding or regulation) and that although it involves genetic testing, the ethical issues involved in...
Pharmacogenetics: the bioethical problem of DNA investment banking [0.03%]
药物基因组学：DNA投资银行业所面临的生命伦理问题
Oonagh P Corrigan,Bryn Williams-Jones
Oonagh P Corrigan
Concern about the ethics of clinical drug trials research on patients and healthy volunteers has been the subject of significant ethical analysis and policy development--protocols are reviewed by Research Ethics Committees and subjects are ...
Tom Ling,Ann Raven
Tom Ling
Uncertainty for policy makers is not new but the pressure to make decisions under conditions of uncertainty is perhaps greater than ever. The arrival of new scientific developments such as pharmacogenetics offers potentially great benefits ...
Combining efficiency and concerns about integrity when using human biobanks [0.03%]
兼顾效率与完整性顾虑的人类生物样本库使用准则
Mats G Hansson
Mats G Hansson
In the debate about human bio-sampling the interests of patients and other sample donors are believed to stand against the interests of scientists and of their freedom of research. Scientists want efficient access to and use of human biolog...